These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23868612)

  • 1. Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain.
    Harada R; Okamura N; Furumoto S; Yoshikawa T; Arai H; Yanai K; Kudo Y
    Mol Imaging Biol; 2014 Feb; 16(1):19-27. PubMed ID: 23868612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.
    Okamura N; Suemoto T; Furumoto S; Suzuki M; Shimadzu H; Akatsu H; Yamamoto T; Fujiwara H; Nemoto M; Maruyama M; Arai H; Yanai K; Sawada T; Kudo Y
    J Neurosci; 2005 Nov; 25(47):10857-62. PubMed ID: 16306398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
    Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease.
    Rabinovici GD; Roberson ED
    Ann Neurol; 2010 Mar; 67(3):283-5. PubMed ID: 20373338
    [No Abstract]   [Full Text] [Related]  

  • 6. Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies.
    Rajasekhar K; Narayanaswamy N; Murugan NA; Viccaro K; Lee HG; Shah K; Govindaraju T
    Biosens Bioelectron; 2017 Dec; 98():54-61. PubMed ID: 28649025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo labeling of amyloid with BF-108.
    Suemoto T; Okamura N; Shiomitsu T; Suzuki M; Shimadzu H; Akatsu H; Yamamoto T; Kudo Y; Sawada T
    Neurosci Res; 2004 Jan; 48(1):65-74. PubMed ID: 14687882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.
    Harada R; Okamura N; Furumoto S; Tago T; Maruyama M; Higuchi M; Yoshikawa T; Arai H; Iwata R; Kudo Y; Yanai K
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):125-32. PubMed ID: 23100049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Near-Infrared Fluorescence Probe THK-565 Enables In Vivo Detection of Amyloid Deposits in Alzheimer's Disease Mouse Model.
    Naganuma F; Murata D; Inoue M; Maehori Y; Harada R; Furumoto S; Kudo Y; Nakamura T; Okamura N
    Mol Imaging Biol; 2023 Dec; 25(6):1115-1124. PubMed ID: 37580462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
    Provias J; Jeynes B
    Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes.
    Yang F; Wang K; Zhou K; Dai B; Dai J; Liang Y; Cui M
    Eur J Med Chem; 2019 Sep; 177():291-301. PubMed ID: 31158745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent BODIPY-based Zn(II) complex as a molecular probe for selective detection of neurofibrillary tangles in the brains of Alzheimer's disease patients.
    Ojida A; Sakamoto T; Inoue MA; Fujishima SH; Lippens G; Hamachi I
    J Am Chem Soc; 2009 May; 131(18):6543-8. PubMed ID: 19368380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.
    Agdeppa ED; Kepe V; Liu J; Flores-Torres S; Satyamurthy N; Petric A; Cole GM; Small GW; Huang SC; Barrio JR
    J Neurosci; 2001 Dec; 21(24):RC189. PubMed ID: 11734604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue.
    Padala S; Setti S; Raymick J; Hanig J; Sarkar S
    Curr Alzheimer Res; 2024; 21(1):69-80. PubMed ID: 38566375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
    Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.